26.04.24 | Vollzeit | Unterschleißheim | Formycon AGOf biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Formycon
Später ansehen26.04.24 | Vollzeit | Unterschleißheim | Formycon AGOf biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Formycon
Später ansehen26.04.24 | Vollzeit | Unterschleißheim | Formycon AGOf biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Formycon
Später ansehen26.04.24 | Vollzeit | Unterschleißheim | Formycon AGOf biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Formycon
Später ansehen26.04.24 | Vollzeit | Unterschleißheim | Formycon AGOf biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Formycon
Später ansehen26.04.24 | Vollzeit | Unterschleißheim | Formycon AGOf biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Formycon
Später ansehen26.04.24 | Vollzeit | Unterschleißheim | Formycon AGOf biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Formycon
Später ansehen26.04.24 | Vollzeit | Unterschleißheim | Formycon AGOf biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Formycon
Später ansehen26.04.24 | Vollzeit | Unterschleißheim | Formycon AGOf biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Formycon
Später ansehenVerpassen Sie nie wieder einen passenden Job!
Alle Jobs für Clinical Immunology in Unterschleißheim kostenlos abonnieren.